StockWatch
·
Pharmaceuticals
Board Meeting10 Aug 2026, 12:28 pm

Lyka Labs Approves Q1 FY27 Results and Divestment of Subsidiary

AI Summary

Lyka Labs Ltd announced that its Board of Directors, in a meeting held on August 10, 2026, approved the unaudited financial results for the first quarter ended June 30, 2026. The company also approved the divestment of its entire 100% equity stake in its subsidiary, Lyka BDR International Limited. Lyka BDR International Limited is confirmed not to be a material subsidiary. The limited review report on the financial results and further disclosures regarding the divestment are attached. The board meeting commenced at 11:00 AM and concluded at 12:20 PM.

Key Highlights

  • Board approved Q1 FY27 unaudited financial results.
  • Approved divestment of 100% stake in Lyka BDR International Limited.
  • Lyka BDR International Limited is not a material subsidiary.
  • Financial results include standalone and consolidated statements.
  • Board meeting held on August 10, 2026.